Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Clinical Pharmacology|November 15, 2000
Pharmacokinetics, pharmacodynamics, and safety of a platelet GPIIb/IIIa antagonist, RGD891, following intravenous administration in healthy male volunteersP N Zannikos, S Rohatagi, B K Jensen, et al.American Journal of Therapeutics|October 1, 1996
Pharmacokinetics and safety of a selegiline transdermal system relative to single-dose oral administration in the elderlyJ S Barrett, T J Hochadel, R J Morales, et al.Journal of Clinical Pharmacology|February 27, 2007
Predictive population pharmacokinetic/pharmacodynamic model for a novel COX-2 inhibitorS Rohatagi, H Kastrissios, Y Gao, et al.Journal of Clinical Pharmacology|March 1, 1997
Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy malesJ S Barrett, T J Hochadel, R J Morales, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 27, 2005
Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthmaZ Diamant, J Kuperus, R Baan, et al.Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 21, 2004
Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonistsF Crofts, S Rohatagi, M Pino, et al.Pageof 4